Growth hormone improves growth in pediatric renal transplant recipients—a systemic review and meta-analysis of randomized controlled trials
Authors:
- 4 June 2012
- journal article
- research article
- Published by Springer Nature in Pediatric Nephrology
- Vol. 28 (1) , 129-133
Abstract
Growth hormone had been applied to treat pediatric renal allograft recipients with growth retardation. In this systemic review and meta-analysis, we assess the efficiency and safety of growth hormone use in post-renal transplant children. A literature search revealed five prospective randomized controlled trials assessing this therapy, with a total of 401 patients. The outcomes, including the baseline height standard deviation score (HSDS), HSDS after a 1-year therapy, delta height standard deviation score (△HSDS), allograft rejection rates and changes in the glomerular filtration rates (GFR) were analyzed. Pooled data of the five studies showed that 1 year after the randomized controlled trials, the experimental group receiving growth hormone had a significantly higher growth velocity than the control group, with a mean HSDS difference of 0.68 [95 % confidence interval (CI) 0.25–1.11, P = 0.002] between the two groups. The mean difference in the △HSDS between the treated and control group was 0.52 (95 % CI 0.37–0.68, P < 0.00001). The rejection episode rates were 35/205 and 19/185, respectively (number of patients with rejection/ total number of patients) (risk ratio 1.56, 95 % CI 0.97–2.53, P = 0.07), and the mean difference in the △GFR was 3.27 ml/min per 1.73 m2 (95 % CI −3.54–10.09, P = 0.35), which was not statistically significant. Based on these studies, we suggest that the application of growth hormone is an effective treatment to promote the growth velocity of children after kidney transplantation. However, the safety of this treatment needs further evaluation.Keywords
This publication has 18 references indexed in Scilit:
- Pediatric renal transplantation: an overview and updateCurrent Opinion in Pediatrics, 2010
- The IGF/IGFBP system in relation to macroscopic bone architecture in pediatric renal transplant patientsPediatric Nephrology, 2009
- Recombinant human growth hormone post-renal transplantation in children: A randomized controlled study of the NAPRTCSKidney International, 2002
- Growth hormone and the skeleton in pediatric renal allograft recipientsPediatric Nephrology, 2002
- Effects of growth hormone in short children after renal transplantationPediatric Nephrology, 1998
- Results and side‐effects of treating children with growth hormone after kidney transplantation – a preliminary reportActa Paediatrica, 1996
- Renal transplantation in children and adolescents: the 1992 Annual Report of the North American Pediatric Renal Transplant Cooperative StudyPediatric Nephrology, 1993
- Shared idiotypes in mesangial deposits in IgA nephropathy are not disease-specificKidney International, 1993
- Renal Transplantation in ChildrenNew England Journal of Medicine, 1992
- Acute renal graft rejection after treatment with human growth hormoneThe Lancet, 1990